Paxman AB (publ)
STO:PAX
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| SE |
P
|
Paxman AB (publ)
STO:PAX
|
1.1B SEK |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
195.2B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
176.1B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
141.2B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
123.5B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
113.1B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
46.8B EUR |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
50.1B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
50.5B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
45.6B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
37.8B USD |
Loading...
|
Market Distribution
| Min | -5 565 412.8% |
| 30th Percentile | -5.3% |
| Median | 3% |
| 70th Percentile | 7.5% |
| Max | 12 228% |
Other Profitability Ratios
Paxman AB (publ)
Glance View
Paxman AB engages in the research and development of scalp cooling system. The company is headquartered in Karlshamn, Blekinge. The company went IPO on 2017-06-12. The cooling system aims to reduce the risk of hair loss connected with cytostatic treatment of cancer. The firm offers a stand-alone, mobile electric cooling unit, which markets under the name Paxman Scalp Cooler, which is a liquid-based cooling system that cools down the patients scalp through the silicone hat. The product has two versions - for one or two patients to be cooled at once. Each device contains a built-in touch screen with a menu-controlled graphic user interface to monitor the process. The lightweight system enables patient to participate in other activities. The Company’s primary markets are Great Britain, Scandinavian countries, the Netherlands, Belgium and Australia.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Paxman AB (publ) is 1.7%, which is below its 3-year median of 5.6%.
Over the last 3 years, Paxman AB (publ)’s Net Margin has increased from -1.7% to 1.7%. During this period, it reached a low of -7.1% on Dec 31, 2022 and a high of 15.9% on Dec 31, 2024.
